ATLANTA, GA — Axion BioSystems today announced that the FDA’s Center for Drug Evaluation and Research (CDER) has accepted the company’s letter of intent (LOI) into the Innovative Science and Technology Approaches for New Drugs (ISTAND) Program for its Human iPSC-Cardiomyocyte MEA Assay for Prediction of Clinical Cardiovascular Repolarization Risk. The submission represents the first stem cell-derived, […]
SAN DIEGO — Singular Genomics, a company delivering high-throughput spatial technologies to advance precision medicine, today announced the commercial launch and U.S. availability of G4X. The launch marks a major milestone in making large-scale spatial multiomics accessible for translational research, spatial pathology, and AI-driven insights. The G4X platform enables simultaneous analysis of 500-plex RNA, 18-plex protein and fH&E […]
3RnD® platform connects targets, compounds and authenticated human cell models to reduce manual searching and enable earlier, more informed R&D decisions By combining Cytion’s authenticated cell models with 3RnD’s data and AI workflow, we enable earlier, more reproducible and more actionable safety insight” — Jonathan Steubing, CEO, Cytion HEIDELBERG, BADEN-WüRTTEMBERG, GERMANY — Cytion, a trusted provider of […]
STOCKHOLM, Sweden — CubaseBio, a biotechnology company founded by pioneers in spatial biology, today announced it has secured €5.9 million in blended financing. The funding comprises a €2 million non-dilutive grant from the European Innovation Council (EIC) Transition program and €3.9 million in private capital and convertibles from Voima Ventures, Nordic Science Investments (NSI), Illumina Ventures, Almi invest, Life Science Invest and […]
The new product offering will supply innovative, high-quality products that exceed the demands of an evolving biologics industry CARLSBAD, CA, UNITED STATES — Cosmo Bio USA, a leading international distributor of life science research products, announced the expansion its product offering with the addition of advanced biologics, cells, tissue culture media and ancillary research products […]
Amsbio has introduced an expanded range of Skeletal Muscle Differentiation Kits designed to reproducibly convert pluripotent or embryonic stem cells into myoblasts with high regenerative potential. Using a simple 3-step process of media changes and cell passaging – these advanced kits can typically achieve 70% MF20-positive myotubes. The highly efficient protocol employed by the kit does not require genetic intervention or cell sorting, […]
HONG KONG — Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In Situ Spatial Transcriptomics services are now available at its Hong Kong Science Park laboratory. Since the launch of the Hong Kong laboratory in July 2025, Omics Empower has supported research teams with local single-cell […]
BOTHELL, Wash. —BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain ctokine and growth factor products manufactured by Qkine for use in cell and gene […]
— Open Aperture provides no-cost access to TfR1 CapX, a leading central nervous system-targeting AAV capsid — NEW YORK, NY – Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced the launch of Open Aperture, a material transfer agreement program that provides qualified academic researchers with access to […]
BOTHELL, Wash. — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain ctokine and growth factor products manufactured by Qkine for use in cell and […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
